About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Schizophrenia Clinical Trials in Chicago | 195 Studies

Clinical Trials SchizophreniaChicago

Schizophrenia Clinical Trials in Chicago

Find 195 clinical trials for schizophrenia near Chicago, Illinois. Connect with research centers in your area.

All Schizophrenia trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 195 trials

CompletedSwitch Study of Existing Atypical Antipsychotics to BifeprunoxThe study will evaluate the safety and tolerability of switching subjects with schizophrenia or schizoaffective disorder from their existing antipsychotic medication to Bifeprunox.NCT00347425·Birmingham, Alabama and 121 others

Schizophrenia Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedTrial to Study the Effect of CVL-231 on 24-Hour Ambulatory Blood Pressure in Participants With SchizophreniaThe purpose of this trial is to characterize the effects of 2 oral doses (over 8 weeks total) of CVL-231 on ambulatory blood pressure and heart rate in patients with stable…NCT05245539·Bentonville, Arkansas and 9 others

CompletedA Trial of the Efficacy and the Safety of RO6889450 (Ralmitaront) vs Placebo in Patients With an Acute Exacerbation of Schizophrenia or Schizoaffective DisorderThis study will investigate the efficacy and safety of RO6889450 as monotherapy in participants experiencing an acute exacerbation of symptoms of schizophrenia or schizoaffective…NCT04512066·Little Rock, Arkansas and 39 others

CompletedLong Term Study of RBP 7000 in the Treatment of Subjects With SchizophreniaThis is a Phase 3, open label study administering RBP-7000 in the treatment of patients with schizophrenia.NCT02203838·Little Rock, Arkansas and 47 others

CompletedOpen-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective DisorderThis is a long-term, open-label clinical study designed to enable longer-term treatment of patients completing other clinical studies with intramuscular olanzapine depot.NCT00088465·Orange, California and 91 others

CompletedAn Open-Label, Multicenter, Rollover, Long-term Study of Aripiprazole Intramuscular Depot in Participants With SchizophreniaThe primary objective of this study was to continue to provide aripiprazole intramuscular (IM) depot treatment (400 milligrams \[mg\] or 300 mg) to participants with schizophrenia…NCT01129882·Bellevue, California and 156 others

RecruitingStudy to Evaluate LB-102 for the Treatment of Adult Patients With Acute SchizophreniaThis is a Phase 3, randomized, double blind, placebo controlled, fixed dose, study designed to evaluate the efficacy, safety, tolerability, and of LB-102 versus placebo for the…NCT07363577·Bentonville, Arkansas and 12 others

RecruitingA Study to Evaluate the Effect of KarXT on Urological SafetyThe purpose of this study is to characterize the effect of KarXT on voiding dynamics and urological safety in participants with DSM-5 schizophrenia.NCT07221877·Little Rock, Arkansas and 15 others

RecruitingA Study of Brenipatide in Adult Participants With SchizophreniaThe purpose of this study is to assess the efficacy and safety of brenipatide when administered with standard of care (SoC) compared to placebo plus SoC for treatment of…NCT07410507·Little Rock, Arkansas and 100 others

TerminatedLong-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)This is a study of ABT-126 in the treatment of cognitive impairment associated with schizophrenia (CIAS), a long-term extension study to study M10-855 (NCT01655680).NCT01834638·Chino, California and 50 others

CompletedSwitching to Iloperidone From Other Antipsychotics in SchizophreniaEvaluate the clinical outcome of two switching strategies to iloperidone treatment in adult subjects with schizophrenia who require a change in their current antipsychotic…NCT01207414·Birmingham, Alabama and 58 others

TerminatedAssessing the Effects of Fanapt® on Social Cognition in SchizophreniaThe study looks at whether treatment with iloperidone (Fanapt) is associated with improvements in social cognition in individuals who have been recently diagnosed with…NCT01929889·Chicago, Illinois

CompletedStudy Comparing the Affect of Bifeprunox Vs Olanzapine on Weight During the Treatment of Outpatients With Schizophrenia.This study will compare bifeprunox to a currently marketed medication, Zyprexa (olanzapine), with respect to the affect on weight during the treatment of outpatients with…NCT00380224·Little Rock, Arkansas and 66 others

TerminatedA Trial in Adult Participants With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite®To compare inpatient psychiatric hospitalization rates while participants are on oral standard-of-care antipsychotic treatment and later switched to Abilify MyCite®.NCT03892889·Phoenix, Arizona and 67 others

CompletedA Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or SchizophreniformThe purpose of the study is to compare effectiveness of paliperidone palmitate (PP: paliperidone palmitate once-monthly and 3-month injections) versus oral antipsychotic (OAP…NCT02431702·Little Rock, Arkansas and 37 others

CompletedClinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-2)This study is open to adults with schizophrenia. Schizophrenia can affect the way a person thinks, their memory and their mental functioning.NCT04846881·Bellflower, California and 126 others

TerminatedCompare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic PatientsThe primary objective of the study is to evaluate changes in weight short and long term with bifeprunox and quetiapine. Study participation for the subject is 57 weeks.NCT00396214·Anaheim, California and 150 others

CompletedOlanzapine Pamoate Depot Versus Oral Olanzapine on Treatment Outcomes in Outpatients With SchizophreniaTo compare the health outcome of patients with schizophrenia, who are at risk for relapse, when treated with a long acting injection form of olanzapine versus treatment with oral…NCT00320489·Escondido, California and 48 others

TerminatedA Long-Term, Open-Label, Study on SchizophreniaThe primary purpose of the study is to help answer the following research questions: How LY 2140023 can be tolerated by patients with Schizophrenia compared to standard of care…NCT01129674·Little Rock, Arkansas and 80 others

TerminatedA Study to Assess the Effects of RO6889450 (Ralmitaront) in Participants With Schizophrenia or Schizoaffective Disorder and Negative SymptomsThis study investigates the effects of RO6889450 on the negative symptoms associated with schizophrenia and schizoaffective disorder.NCT03669640·Bellflower, California and 44 others

Page 1 of 10Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia